<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        14-887-17
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2017
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        TRANDATE INJ. 100 MG.-AMP.20ML
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        LABETALOL HYDROCHLORIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        100
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intravenous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Solution for injection
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Ampoule
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        44.90
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="CENEXI" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            CENEXI
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 583]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            ALNAGHI COMPANY
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            ASPEN PHARMA TRADING LIMITED (APTL)
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        C07AG01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>1. What Trandate is and what it is used for</strong><br />Trandate contains the active substance labetalol. It is used to treat severe hypertension (high blood pressure), including severe hypertension of pregnancy (high blood pressure caused by pregnancy) when rapid control of the blood pressure is necessary. Trandate can also be used to keep the blood pressure under control during general anaesthesia.</p><p>Labetalol (Trandate) belongs to a group of medicines called alpha and beta blockers. These medicines reduce the blood pressure by blocking receptors in the cardiovascular system (the circulatory system), which reduces blood pressure in the blood vessels far away from the heart.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>2. What you need to know before you are given Trandate</strong></p><p><strong>Trandate should not be used</strong></p><p>- if you have certain heart problems (such as second or third degree heart block, unless you have pacemaker; untreated heart failure)<br />- if you have low blood pressure<br />- if you have an extremely slow heart rate (severe bradycardia)<br />- if you have a condition called Prinzmetal angina (variant angina)<br />- if you have asthma or a similar lung disease (obstructive airway disease)<br />- if you are allergic to labetalol or any of the other ingredients of this medicine (listed in section 6).</p><p><strong>Warnings and precautions</strong></p><p>Talk to your doctor or pharmacist before using Trandate:<br />- if you have impaired liver function or liver damage<br />- if you have impaired kidney function<br />- if you have peripheral vascular disease, such as Raynaud syndrome (claudication)<br />- if you have diabetes mellitus (type 1 or type 2)<br />- if you have an overactive thyroid gland (thyrotoxicosis, hyperthyroidism)<br />- if you have previously had a severe allergic reaction (allergic shock) to any substance<br />- if you have heart failure or other problems with your heart (such as impaired systolic function in the left ventricle or first degree atrioventricular block)<br />- if you know that you will undergo planned surgery<br />- if you have metabolic acidosis (when your body produces too much acid or when your kidneys do not remove enough acid from your body)<br />- if you have phaeochromocytoma (a particular type of tumour in the adrenal gland)<br />- if you have a condition called ischemic heart disease<br />- if you have any problems with your lungs or airways</p><p>If you get a low heart rate (bradycardia) as a result of using Trandate, the doctor can lower your dose.</p><p>If you get a skin rash and/or dry eyes or any kind of allergic reaction when you use Trandate, you should contact your doctor who can then decrease your dose or stop your treatment.</p><p><strong>Surgery</strong></p><p>If you are to undergo surgery under general anaesthesia, you must tell the surgeon that you are using Trandate before the operation.</p><p>Labetalol can affect your pupils during cataract surgery. Tell the eye surgeon that you are using this medicine before the operation. Do not stop using labetalol before the operation unless the surgeon tells you to do so.</p><p><strong>Other medicines and Trandate</strong></p><p>Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines before you are prescribed Trandate. This is particularly important for the following medicines:<br />- non-steroidal anti-inflammatory drugs (NSAIDs)/anti-rheumatic agents such as sulindac or indomethacin, which are used to treat pain and inflammation.<br />- digoxin (heart medicine)<br />- adrenaline, which can be used to treat severe anaphylactic (allergic) reactions<br />- medicines for heart problems (class I antiarrhythmics such as disopyramide and quinidine, and class II antiarrhythmics such as amiodarone)<br />- other medicines that reduce blood pressure (calcium channel blockers such as verapamil)<br />- general anaesthetics (used as anaesthesia during surgery)<br />- tricyclic antidepressants, such as imipramine (used for the treatment of depression)<br />- oral antidiabetic agents such as biguanides (e.g. metformin), sulphonylureas (e.g. glimepiride), meglitinides (e.g. repaglinide), and alpha-glucosidase inhibitors (e.g. acarabose), that are used to decrease the blood sugar level<br />- ergotamine derivatives, such as ergotamine or dihydroergotamine, that are used to treat migraine<br />- cholinesterase inhibitors, such as: donepezil, galantamine or rivastigmine, which are used to treat mild cognitive disorders, Alzheimer&rsquo;s disease and Parkinson&rsquo;s disease<br />- nitrates, antipsychotics (e.g. phenothiazines, chlorpromazine), antidepressants<br />- clonidine, which is used to treat high blood pressure.</p><p><strong>Tests</strong></p><p>This medicine can affect certain medical tests/laboratory tests and potentially lead to incorrect test results. Make sure that the laboratory staff and all your doctors know that you are using this medicine.</p><p><strong>Pregnancy, breast-feeding and fertility</strong></p><p>If you are pregnant or are planning to have a baby, ask your doctor for advice before using Trandate. It is possible that the foetus may be affected, but Trandate can be used when it is necessary to quickly control blood pressure during pregnancy.</p><p>Trandate is excreted in breast milk. Breast feeding is therefore not recommended. If you are breast-feeding, ask your doctor for advice before using Trandate.</p><p>Nipple pain have been reported.</p><p><strong>Driving and using machines</strong><br />You alone are responsible to decide if you are in a fit condition to drive a motor vehicle or perform other tasks that demand increased concentration. Because of their effects and/or side effects, one of the factors that can reduce your ability to do these things safely is your use of medicines. Descriptions of these effects and side effects can be found in other sections. Read all the information in this leaflet for guidance. Discuss with your doctor or pharmacist if you are unsure about anything.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>3. How you will be given Trandate Injection</strong></p><p>Trandate Injection is usually only given to patients in hospital by a doctor or anaesthetist. It may be given as an injection into a vein, or by a slow drip, depending on how quickly your blood pressure needs to be reduced.</p><p>IMPORTANT: Your doctor will decide how the Trandate Injection will be given to you and the correct dose for you.</p><p>Remember: You should only be given this drug if you are lying down.<br />You should avoid sitting upright for three hours after being given Trandate Injection as you may feel very dizzy and lightheaded.<br />While you are having Trandate Injection your doctor may check your heart rate, blood pressure and breathing, to check your medicine is working properly.</p><p>Adults:<br />Injection into a vein (to reduce blood pressure very quickly)</p><ul><li>&nbsp;A dose of 50mg of Trandate Injection will be given into your vein over a period of one minute.</li><li>If necessary this dose can be repeated every five minutes up to three times until your blood pressure has been lowered.</li><li>&nbsp;The total dose should not exceed 200mg. Slow drip into a vein (to reduce blood pressure more slowly).</li><li>&nbsp;A solution containing 1mg/ml Trandate Injection will be made up by the doctor or nurse.</li><li>&nbsp;The solution will then be given to you via a drip into your vein.</li><li>&nbsp;The amount of the solution you will be given will depend on why your blood pressure needs to be lowered:</li></ul><p>1. To lower high blood pressure in pregnancy</p><ul><li>&nbsp;20mg of Trandate Injection will be given over one hour.</li><li>&nbsp;The dose may then be doubled every 30 minutes until your blood pressure has been reduced or the dose has reached 160mg per hour.</li><li>Your doctor may occasionally need to use a higher dose.</li></ul><p>2. To lower high blood pressure after a heart attack</p><ul><li>15mg of Trandate Injection will be given over one hour.</li><li>The dose may then be gradually increased up to a maximum of 120mg per hour if needed.</li></ul><p>3. To lower high blood pressure for other reasons</p><ul><li>&nbsp;2mg of Trandate Injection will be given per minute.</li><li>&nbsp;When your blood pressure is low enough, the doctor will stop your drip.</li><li>&nbsp;Your doctor may change the rate at which the drip goes in depending on how well you are responding to the medicine.</li><li>&nbsp;The total dose given is usually between 50mg and 200mg, but occasionally higher doses may be needed.</li></ul><p>To lower blood pressure during an operation</p><ul><li>&nbsp;Whilst you are under anaesthetic, 10-20mg Trandate Injection (depending on your age and health) will be injected into your vein.</li><li>&nbsp;If after five minutes your blood pressure has not been reduced, a dose of 5-10mg can be given every five minutes until your blood pressure is low enough.</li></ul><p>Maintaining your blood pressure<br />After you have had Trandate Injection your doctor may suggest you take Trandate tablets to keep your blood pressure low.</p><ul><li>&nbsp;If this applies to you, your doctor or pharmacist will tell you exactly how many tablets to take and when to take them.</li></ul><p>People with liver or kidney problems:<br />If you have problems with your liver or kidneys, your doctor may give you a lower dose of Trandate Injection.</p><p>The elderly (65 years and over):<br />Your doctor may start you on a lower dose than the usual adult dose to make sure that the medicine is working properly.</p><p>Children:<br />Trandate Injection is not recommended for use in children.</p><p>If you are given more Trandate Injection than you should</p><p>If you think you may have been given too much Trandate Injection, tell your doctor immediately.</p><p>If you have any further questions about the use of this medicine, ask your doctor.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>4. Possible side effects</strong></p><p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p><strong>Common: may affect up to 1 in 10 users</strong><br />- heart failure<br />- dizziness due to low blood pressure if you move too quickly from a lying to a sitting position, or from a sitting to standing position (postural hypotension). This may occur within three hours after the injection of Trandate. It is usually transient and occurs during the first weeks of treatment.<br />- nasal congestion, which is usually transient and occurs during the first weeks of treatment<br />- elevated liver function tests. These usually return to normal once you have stopped using the medicine.<br />- erectile dysfunction (impotence)<br />- allergic reactions (hypersensitivity) can also include skin rash (of varying severity), itching, breathlessness and, very rarely, fever or rapid swelling of the skin.</p><p><strong>Uncommon: may affect up to 1 in 100 users</strong><br />- constriction of the lower airways (bronchospasm)</p><p><strong>Rare: may affect up to 1 in 1,000 users</strong><br />- low heart rate, which can be felt as a slow pulse (bradycardia)</p><p><strong>Very rare: may affect up to 1 in 10,000 users</strong><br />- disturbances to the electric impulses that control the heart beat (heart block)<br />- aggravated symptoms of Raynaud syndrome (cold fingers due to decreased blood circulation)<br />- inflammation in the liver (hepatitis) which usually subsides once Trandate treatment is stopped<br />- hepatocellular jaundice (the skin and the whites of the eyes turn yellow), cholestatic jaundice (symptoms include fatigue and nausea followed by itching, dark urine and jaundice, and may include skin rash or fever) and hepatic necrosis (damaged liver tissue). These symptoms usually subside once Trandate treatment is stopped.</p><p><strong>Not known frequency:</strong><br />- Nipple pain, Raynaud&#39;s phenomenon of the nipple (a phenomenon associated with less blood flow to the nipple).</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>5. How to store Trandate</strong><br />Keep this medicine out of the sight and reach of children.</p><p>Store below 25&deg;C.<br />Do not use this medicine after the expiry date which is stated on the carton after &lsquo;Utg.dat.&rsquo;. The expiry date refers to the last day of that month.</p><p>Do not use the medicine if you notice signs of deterioration of the quality of the product. Any unused solution must be discarded 24 hours after preparation.</p><p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>What Trandate contains</strong><br />- The active substance is labetalol hydrochloride. 1 ml of solution contains 5 mg labetalol hydrochloride.<br />- The other ingredients are water for injections, diluted hydrochloric acid and sodium hydroxide (for pH adjustment).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                What Trandate looks like and contents of the pack
Trandate is a clear, colourless or almost colourless solution and is supplied in a clear glass ampoule.
Each pack contains five 20 ml ampoules. Each ampoule contains 100 mg labetalol hydrochloride (5 mg/ml).
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Marketing Authorisation Holder and Manufacturer</strong></p><p><strong>Marketing Authorisation Holder</strong><br />Aspen Pharma Trading Limited 3016 Lake Drive<br />Citywest Business campus Dublin 24<br />Ireland</p><p><strong>Manufacturer</strong><br />Cenexi SAS, 52 rue Marcel et Jaques Gaucher, 94120 Fontenay-Sous-Bois, France</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised in {February/2022}; version number {6}.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p><strong>1 . ما هو تراندات وما هي دواعي استخدامه</strong><br />يحتوي تراندا ت على المادة الفعالة لابيتالول، وهي مادة تستخدم في علاج ارتفاع الضغط الحاد ( ارتفاع ضغط الدم )، بما في ذلك ارتفاع الضغط الحاد في حالة الحمل ( ارتفاع ضغط الدم الناجم عن الحمل) عندما تكون سرعة السيطرة على ضغط الدم ضرورية .<br />يمكن أيضا استخدام تراندات للحفاظ على ضغط الدم تحت السيطرة أثناء التخدير الكلي .</p><p>ينتمي لابيتالول (تراندات) إلى مجموعة من الأدوية تُدعى حاصرات ألفا وبيتا. تقوم هذه المجموعة من الأدوية بخفض ضغط الدم عن طريق حصر مستقبلات الجهاز القلبي الوعائي (الجهاز الدوري)، مما يؤدي إلى انخفاض ضغط الدم في الأوعية الدموية البعيدة عن القلب .</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>2. ما الذي تحتاج لمعرفته قبل تلقي تراندات</strong></p><p><strong>يجب الامتناع عن استخدام تراندا ت في الحالات التالية</strong></p><p>- إذا كنت مصابا بمشاكل قلبية محددة (مثل إحصار القلب من الدرجة الثانية أو الثالثة، عدا في حالة وجود الناظمة القلبية الاصطناعية، أو الإصابة بفشل قلبي غير معالج)<br />- إذا كنت تعاني من ضغط الدم المنخفض<br />- إذا كانت ضربات القلب لديك متباطئة للغاية (بطء القلب الحاد)<br />- إذا كنت مصابا بحالة تُدعى ذبحة برنزميتال (الذبحة الصدرية المتغير ة)<br />- إذا كنت تعاني من مرض الربو أو أي من الأمراض الرئوية المشابهة (داء الانسداد الرئو ي) .<br />- إذا كنت تعاني من حساسية لمادة اللابيتالول أو لأي من مكونات الدواء الأخرى (لمذكورة في القسم 6).</p><p><strong>التحذيرات والاحتياطات</strong><br />تحدث مع طبيبك أو الصيدلي قبل استخدام تراندات :<br />- إذا كنت مصابا بقصور في وظائف الكبد أو ضرر كبدي<br />- إذا كنت مصابا بقصور في وظائف الكلى<br />- إذا كنت مصابا بمرض وعائي محيطي، مثل متلازمة رينود (عرج)<br />- إذا كنت مصابا بداء السكري (النوع الأول أو الثاني)<br />- إذا كنت مصابا بفرط نشاط الغدة الدرقية (التسمم الدرقي)<br />- إذا سبق وعانيت من رد فعل تحسسي حاد (صدمة تحسسية)&nbsp;لأي مادة .<br />- إذا كنت مصابا بفشل قلبي أو مشكلات قلبية أخرى(مثل قصور الوظيفة الانقباضية في البطين الأيسر أو إحصار أذيني بطيني&nbsp;من الدرجة الأولى)<br />- إذا كنت تعرف أنه من المقرر أن تخضع لجراحة<br />-إذا كنت مصابا بحماض أيضي (عندما ينتج الجسم أحماضا بكمية أكبر من اللازم أو عندما لا تطرح الكلى الأحماض بكمية كافية من الجسم)<br />- إذا كنت مصابا بورم القواتم (نوع من الأورام يصيب الغدة الكظرية)<br />- إذا كنت مصابا بحالة تدعى داء قلبي إقفار ي<br />- إذا كنت تعاني من أي مشكلات بالرئة أو المسالك التنفسية</p><p>إذا تعرضت لتباطؤ ضربات القلب(بطء القلب) نتيجة لاستخدام تراندات، يمكن للطبيب تقليل الجرعة التي تتلقاها.</p><p>إذا أصبت بطفح جلدي و/أو جفاف العيون أو أي نوع من رد الفعل التحسسي عند استخدام تراندات، فينبغي عليك الاتصال بالطبيب الذي يمكنه حينها خفض الجرعة التي تتلقاها أو إيقاف العلاج .</p><p><strong>الجراحة</strong><br />إذا كان من المقرر أن تخضع للجراحة تحت تخدير كلي، يجب أن تخبر الجراح أنك تستخدم تراندا ت قبل العملية، حيث من الممكن أن تؤثر مادة اللابيتالول على حدقتي العينين أثناء جراحة إعتام عدسة العين. أخبر جراح العيون أنك تستخدم هذه المادة قبل العملية.<br />لا تنقطع عن استخدام مادة اللابيتالول قبل العملية إلا إذا أخبرك الطبيب بذلك .</p><p><strong>الأدوية الأخرى وتراندات</strong><br />أخبر طبيبك أو الصيدلي إن كنت تتناول أو تناولت مؤخراً أو قد تتناول أي أدوية أخرى قبل أن يوصف لك تراندات. ويُعد هذا أمرا هاما خاصة مع الأدوية التالية :<br />- مضادات الالتهاب اللاستيرويدية (NSAID) /مضادات الروماتيزم، مثل سلينداك أو إندوميثاسين، وهما يستخدمان لعلاج الآلام والالتهابات .<br />- الديجوكسين (دواء للقلب)<br />- الأدرينالين، الذي يمكن استخدامه لعلاج ردود الفعل التأقية (التحسسية) الحادة<br />- أدوية علاج المشكلات القلبية (مضادات اضطرابات نظم القلب من الفئة الأولى مثل ديسوبيراميد وكوينيدين، ومضادات اضطرابات نظم القلب من الفئة الثانية مثل أميودارون)<br />- أدوية أخرى لخفض ضغط الدم (حاصرات قناة الكالسيوم مثل فيراباميل)<br />- أدوية التخدير الكلي (التي تُستخدم للتخدير أثناء الجراحات)<br />- مضادات الاكتئاب ثلاثية الحلقات، مثل إميبرامين (ستخدم لعلاج الاكتئاب)<br />- مضادات السكري التي تؤخذ عن طريق الفم مثل مجموعة البيغوانيد (مثل ميتفورمين)، السلفونيل يوريا (مثل جليميبرايد)،<br />- ومجموعة ميجليتنايدز (مثل ريباجلينيد)، ومثبطات الجلوكوسيديز ألفا (مثل أكاربوز ) التي تُستخدم في خفض مستوى سكر الدم<br />- مُشتقات الإرجوتامين، مثل إرجوتامين أو ثنائي هيدرات الإرجوتامين، التي تستخدم في علاج الشقيقة<br />- مثبطات الكولينستيراز، مثل: دونيبيزيل، أو جالانتامين، أو ريفاستجمين، وهي تستخدم في علاج الاضطرابات الإدراكية متوسطة الشدة، ومرض ألزهايمر ومرض باركنسون<br />- النترات، مضادات الذهان (مثل فينوثيازين، كلوربرومازين)، مضادات الاكتئاب<br />- كلونيدين، يُستخدم في علاج ارتفاع ضغط الدم .</p><p><strong>الاختبارات</strong><br />يمكن لهذا الدواء أن يؤثر على اختبارات معملية/ اختبارات طبية محددة وقد يؤدي إلى ظهور نتائج غير صحيحة للاختبارات.<br />أحر ص على أن تخبر الفريق الطبي بالمعمل وجميع أطبائك بأنك تستخدم هذا الدواء .</p><p><strong>الحمل والرضاعة الطبيعية والخصوبة</strong><br />إذا كنتِ حاملاً، أو تخططين للإنجاب، اطلبي المشورة من طبيبك قبل تلقي تراندات. فمن المحتمل أن يتأثر الجنين، إلا أنه من الممكن استخدام تراندات عند الضرورة للتحكم السريع في ضغط الدم خلال فترة الحمل .</p><p>يُفرز تراندات في حليب الثدي. لذا لا يوصى بالرضاعة الطبيعية. اطلبي من طبيبك المشورة قبل تلقي تراندات .</p><p>وردت بلاغات عن حدوث ألم في حلمات الثدي .</p><p><strong>القيادة واستخدام الآلات</strong><br />أنت وحدك المسؤول عن تحديد إذا ما كنت في حالة تسمح لك بالقيادة أو أداء أي مهام أخرى تتطلب المزيد من التركيز. ونظراً لآثارها أو آثارها الجانبية، يعد استخدام الأدوية أحد العوامل التي قد تخفض قدرتك على القيام بهذه المهام بأمان. يمكن إيجاد وصف هذه الآثار و الآثار الجانبية في الأقسام الأخرى. يُرجى قراءة جميع المعلومات الواردة في هذه النشرة لل حصول على التوجيهات.</p><p>استشر طبيبك أو الصيدلي إذا لم تكن متأكدًا من أي شيء .</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>3. كيفية تلقي حقن تراندات</strong><br />يتم عادة إعطاء حقن تراندا ت فقط للمرضى النزلاء بالمستشفيات على يد الأطباء أو أخصائيي التخدير. قد يتم إعطاؤها كحقن في الوريد، أو بالتنقيط البطيء، وذلك بحسب السرعة اللازمة لخفض ضغط الدم .</p><p>هام: يقرر الطبيب الطريقة التي ستعطى بها حقن تراندا ت والجرعة الأنسب لك .</p><p>تذكر: يجب تلقي هذا الدواء فقط في وضعية الاستلقاء .<br />يجب تجنب وضعية الجلوس القائم لثلاث ساعات بعد تلقي حقن تراندات حيث قد تشعر بدوّار شديد ودوخة .<br />أثناء تلقي حقن تراندات، قد يقوم الطبيب بفحص معدل ضربات القلب، وضغط الدم، والتنفس، وذلك لمعرفة إذا ما كان الدواء فعال&nbsp;كما ينبغي.</p><p>البالغون:<br />الحقن في الوريد (لخفض ضغط الدم بسرعة شديدة) .</p><ul><li>&nbsp;يتم إعطاء جرعة 50 ملجم من حقن تراندات في الوريد على مدار دقيقة واحدة .</li><li>عند اللزوم، يمكن تكرار هذه الجرعة كل خمس دقائق حتى ثلاث مرات إلى أن ينخفض ضغط الدم .</li><li>&nbsp;يجب ألا تتجاوز الجرعة الإجمالية 200 ملجم. التنقيط البطيء في الوريد (لخفض ضغط الدم بسرعة أقل).</li><li>&nbsp;يقوم الطبيب أو الممرضة بتحضير محلول يحتوي على 1 ملجم/مل من حقن تراندات .</li><li>وبعدها سيتم إعطاؤك المحلول عبر التنقيط في الوريد .</li><li>&nbsp;تكون كمية المحلول المقدمة لك بحسب السبب الذي تحتاج من أجله إلى خفض ضغط الدم .</li></ul><p>لخفض ضغط الدم المرتفع في حالة الحمل</p><ul><li>سيقدم لكِ 20 ملجم من حقن تراندات على مدار ساعة واحدة .</li><li>&nbsp;بعد ذلك يمكن مضاعقة الجرعة كل 30 دقيقة إلى أن ينخفض ضغط الدم أو تصل الجرعة إلى 160 ملجم /ساعة .</li><li>&nbsp;قد يحتاج الطبيب في بعض الأحيان إلى استخدام جرعة أعلى .</li></ul><p>لخفض ضغط الدم المرتفع بعد الأزمات القلبية</p><ul><li>&nbsp;يقدم 15 ملجم من حقن تراندات على مدار ساعة واحدة .</li><li>&nbsp;يمكن بعدها رفع الجرعة تدريجيا لتصل إلى الحد الأقصى الذي يبلغ 120 ملجم /ساعة عند الضرورة .</li></ul><p>لخفض ضغط الدم لأسباب أخر ى</p><ul><li>&nbsp;يقدم 2 ملجم/دقيقة من حقن تراندات .</li></ul><p>عند انخفاض ضغط الدم لدرجة كافية، يوقف الطبيب التنفيط .</p><ul><li>&nbsp;قد يغير الطبيب السرعة التي يتم بها التنقيط بحسب استجابتك للدواء .</li><li>&nbsp;عادة ما تكون الجرعة الإجمالية المقدمة ما بين 50 ملجم و 200 ملجم، لكن في بعض الأحيان قد يلزم تقديم جرعات أعلى .</li></ul><p>لخفض ضغط الدم أثناء العمليات الجراحية</p><ul><li>عندما يكون المريض تحت التخدير، يتم إعطاؤه حقنة في الوريد 10 - 20 ملجم من حقن تراندا ت (بحسب الحالة الصحية والسن).</li><li>في حالة عدم انخفاض ضغط الدم بعد مرور خمس دقائق، يمكن إعطاء المريض جرعة من 5 - 10 ملجم كل خمس دقائق إلى أن ينخفض ضغط الدم بدرجة كافية .</li></ul><p>الحفاظ على مستوى ضغط الدم</p><ul><li>&nbsp;بعد تلقي حقن تراندات، قد يشير عليك الطبيب بتناول أقراص تراندات للحفاظ على انخفاض ضغط الدم .</li><li>&nbsp;إذا كان ذلك ينطبق عليك، سيخبرك الطبيب أو الصيدلي بالضبط بعدد الأقراض التي يجب تناولها ووقت تناولها .</li></ul><p>المصابون بمشاكل كبدية أو كلوية :<br />إذا كنت تعاني من مشاكل كبدية أو كلوية، قد يعطيك الطبيب جرعة أقل من حقن تراندات .</p><p>المسنون(65 عاما وأكبر):<br />قد يبدأ الطبيب علاجك بجرعة أقل من جرعة البالغين المعتادة للتأكد مما إذا كان الدواء فعالا كما ينبغي</p><p>الأطفال :<br />لا يوصى باستخدام حقن تراندا ت للأطفال .<br />في حالة تلقي حقن تراندات بكمية أكبر مما ينبغي إذا كنت تعتقد أنك تلقيت كمية أكبر مما ينبغي من حقن تراندات، أخبر طبيبك على الفور .</p><p>إذا كان لديك أي استفسارات أخرى حول استخدام هذا الدواء، فأسأل طبيبك.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p><strong>4. الآثار الجانبية المحتملة</strong><br />مثل جميع الأدوية، يمكن لهذا الدواء أن يسبب آثاراً جانبية، على الرغم من أنه ليس بالضرورة أن يعاني منها الجميع .</p><p><strong>شائعة: قد تؤثر على 1 من كل 10 مستخدمين</strong><br />- فشل القلب<br />- الدوّار الناتج عن انخفاض ضغط الدم عند التغيير السريع من وضع الاستلقاء إلى وضعية الجلوس، أو من وضعية الجلوس<br />- إلى الوقوف (هبوط ضغط الدم الوضعي). قد يحدث ذلك خلال ثلاث ساعات بعد حقن محلول تراندات. عادة ما يكون هذا التأثير مؤقتا،ً ويحدث خلال الأسابيع الأولى من العلاج .<br />- احتقان الأنف، وعادة ما يكون هذا التأثير مؤقتا،ً ويحدث خلال الأسابيع الأولى من العلاج .<br />- نتائج مرتفعة في اختبارات وظائف الكبد عادة ما تعود هذه النتائج إلى المستوى الطبيعي بمجرد التوقف عن استخدام الدواء .<br />- ضعف الانتصاب(ضعف جنسي) .<br />- تفاعلات تحسسية (فرط حساسية) قد تتضمن أيضا الطفح الجلدي(بدرجات شدة متفاوتة)، والحكة، وصعوبة في التنفس، وقد<br />- وقد&nbsp;يحدث في بعض الحالات النادرة للغاية حمى، أو تورم سريع في الجلد .</p><p><strong>غير شائعة: قد تؤثر على 1 من كل 100 مستخدم</strong><br />- تضيّق المسالك التنفسية السفلية (تشنج قصبي).</p><p><strong>نادرة: قد تؤثر على 1 من كل 1000 مستخدم</strong><br />- تباطؤ ضربات القلب، والذي يمكن الشعور به كنبض بطيء (بطء القلب)</p><p><strong>نادرة جداً: قد تؤثر على 1 من كل 10000 مستخدم</strong><br />- اضطرابات في النبضات الكهربائية التي تتحكم في نبضات القلب (انسداد القلب).<br />- تفاقم أعراض متلازمة رينود (برودة الأصابع بسبب ضعف الدورة الدموية) .<br />- التهاب في الكبد (التهاب كبدي) عادة ما يزول عند إيقاف العلاج بدواء تراندات<br />- يرقان خلوي كبدي (اصفرار الجلد وبياض العينين)، يرقان ركود الصفراء (تتضمن الأعراض الشعور بالتعب والغثيان، متبوعة بحكة، ولون داكن للبول ويرقان، وقد يتضمن أيضا طفحا جلديا أو حمى)، والنخر الكبدي (تضرر في نسيج الكبد).<br />عادة ما تتراجع هده الأعراض بمجرد إيقاف العلاج بدواء تراندات .</p><p><strong>معدل الحدوث غير معروف :</strong><br />ألم في حلمات الثدي، ظاهرة رينو في حلمات الثدي (ظاهرة مرتبطة بانخفاض تدفق الدم إلى الحلمات).</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>5 . كيفية تخزين تراندات</strong></p><ul><li>يُحفظ هذا الدواء بعيداً عن مرأى ومتناول الأطفال .</li><li>&nbsp;يخزن في أقل من 25 درجة مئوية .</li><li>&nbsp;لا تستخدم هذا الدواء بعد تاريخ انتهاء الصلاحية الموضح على العلبة الكرتونية بعد عبارة &quot;تاريخ انتهاء الصلاحية&quot; (Exp.) يشير إلى تاريخ انتهاء الصلاحية إلى آخر يوم من ذلك الشهر .</li><li>&nbsp;لا تستخدم هذا الدواء إذا لاحظت أي تدهور في جودة المنتج .</li><li>&nbsp;يجب التخلص من أي محلول غير مستخدم بعد مرور 24 ساعة من التحضير .</li><li>&nbsp;لا تتخلص من أي أدوية في ماء الصرف الصحي أو مع المخلفات المنزلية. واسأل الصيدلاني عن كيفية التخلص من الأدوية التي لم تعد بحاجة إليها. ستساعد هذه الإجراءات في الحفاظ على البيئة .</li></ul>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>ما هي محتويات تراندات :</strong><br />- المادة الفعالة هي لابيتالول هيدروكلوريد. 1 مل من المحلول يحتوي 5 ملجم لابيتالول هيدروكلوريد .<br />- المكونات الأخرى هي ماء للحقن، حمض هيدروكلوريك مخفف وهيدروكسيد الصوديوم (لضبط درجة الحموضة)</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p><strong>كيف يبدو تراندات وما هي محتويات العبوة</strong><br />تراندات محلول صاف عديم اللون أو عديم اللون تقريبا،ً يُورد في أمبولات زجاجية شفافة. تحتوي كل عبوة على خمس أمبولات 20 مل. يحتوي كل أمبول على 100 ملجم لابيتالول هيدروكلوريد (5 ملجم/مل)</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p><strong>مالك حق التسويق والمُصَّنع</strong><br />أسبن فارما تريدينغ المحدودة<br />3016 ليك درايف ،<br />مجمع سيتي ويست للأعمال<br />دبلن 24<br />أيرلندا</p><p><strong>المُصَّنع :</strong><br />سينكسي شركة مساهمة بسيطة، 52 شارع مارسيل إيه جاك جوشيه، 94120 فونتيناي سو بوا، فرنسا</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تمت مراجعة هذه النشرة في{فبراير/ 2022} ، رقم النسخة{6}
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Trandate 5 mg/ml solution for injection
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                1 ml contains 5 mg labetalol hydrochloride. 

For the full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Solution for injection.

Trandate is a clear, colourless or almost colourless solution and is supplied in a clear glass ampoule.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <ul><li>&nbsp;Severe hypertension, including severe hypertension of pregnancy when rapid control of the blood pressure is necessary.</li><li>Can be used to achieve controlled hypotension during general anaesthesia.</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Adults:</p><p>Trandate Injection/Labetalol Injection is intended for intravenous use in hospitalised patients. The plasma concentrations achieved after intravenous dose of labetalol in severe hypertension are substantially greater than those following oral administration of the drug and provide a greater degree of blockade of alpha-adrenoceptors necessary to control the more severe disease. Patients should, therefore, always receive the drug whilst in the supine or left lateral position. Raising the patient into the upright position, within three hours of intravenous labetalol administration, should be avoided since excessive postural hypotension may occur.</p><p>Bolus injection</p><p>If it is essential to reduce blood pressure quickly, as for example, in hypertensive encephalopathy, a dose of 50mg of labetalol hydrochloride should be given by intravenous injection over a period of at least one minute. If necessary, doses of 50mg may be repeated at five minute intervals until a satisfactory response occurs. The total dose should not exceed&nbsp;200mg. After bolus injection, the maximum effect usually occurs within five minutes and the effective duration of action is usually about six hours but may be as long as eighteen hours.</p><p>Intravenous infusion</p><p>An alternative method of administering labetalol is intravenous infusion of a solution made by diluting the contents of two 20 ml ampoules or eight 5 ml ampoules (200mg) to 200ml with Sodium Chloride and Dextrose Injection BP or 5% Dextrose Intravenous Infusion BP. The resultant infusion solution contains 1mg/ml solution of labetalol hydrochloride.</p><p>In the case of severe hypertension of pregnancy, a slower and increasing rate of infusion should be used: The infusion can be started at the rate of 20mg per hour and this dose may be doubled every thirty minutes until a satisfactory reduction in blood pressure has been obtained or a dosage of 160mg per hour is reached. Occasionally, higher doses may be necessary.</p><p>In hypertension due to other causes: The rate of infusion of labetalol hydrochloride should be about 2mg (2ml of infusion solution) per minute, until a satisfactory response is obtained; the infusion should then be stopped. The effective dose is usually in the range of 50-200mg depending on the severity of the hypertension. For most patients it is unnecessary to administer more than 200mg but larger doses may be required especially in patients with phaeochromocytoma. The rate of infusion may be adjusted according to the response, at the discretion of the physician. The blood pressure and pulse rate should be monitored throughout the infusion.</p><p>It is desirable to monitor the heart rate and blood pressure after injection and during infusion. In most patients, there is a small decrease in the heart rate; severe bradycardia is unusual but may be controlled by injecting atropine 1-2 mg intravenously. Respiratory function should be observed particularly in patients with any known impairment.</p><p>Once the blood pressure has been adequately reduced by bolus injection or infusion, maintenance therapy with labetalol tablets should be substituted with a starting dose of 100 mg tablet twice daily (see labetalol tablet SmPC for further details). Trandate Injection/Labetalol Injection has been administered to patients with uncontrolled hypertension already receiving other hypotensive agents, including beta-blocking drugs, without adverse effects.</p><p>To achieve controlled hypotension during anaesthesia, the recommended starting dose of labetalol injection is 10 to 20 mg intravenously depending on the age and condition of the patient.</p><p>If satisfactory hypotension is not achieved after 5 min, increments of 5 to 10 mg should be given until the desired level of blood pressure is attained.</p><p>The mean duration of hypotension following 20 to 25 mg of labetalol is 50 min.</p><p>Children:<br />Safety and efficacy have not been established.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                • Nonselective beta blockers must not be used in patients with asthma or a history of obstructive airway disease.
• Labetalol injections and tablets are contraindicated in second or third degree heart block (unless a pacemaker is present), cardiogenic shock and other conditions associated with severe and prolonged hypotension or severe bradycardia
• Uncompensated heart failure
• Unstable/uncontrolled cardiac insufficiency
• Sick sinus syndrome (including sino-atrial block) unless a pacemaker is present
• Prinzmetal angina
• Sinus node dysfunction
• Labetalol injection and tablets are contraindicated for patients with known hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Hepatic disease</strong><br />Caution must be observed in the presence of liver disease. There have been very rare reports of severe hepatocellular injury with labetalol therapy. The hepatic injury is usually reversible and has occurred after both short-term and long-term treatment. However, hepatic necrosis has been reported and in some cases been fatal. Laboratory testing should be done at the first sign or symptom of hepatic dysfunction. If laboratory results show hepatic injury or the patient is jaundiced, labetalol therapy should be discontinued and not resumed.</p><p>Particular caution must be observed when labetalol is used in patients with hepatic impairment, as such patients metabolise labetalol slower than patients without hepatic impairment.</p><p><strong>Renal impairment</strong><br />Caution must be observed when labetalol is used in patients with severe renal impairment (GFR = 15&ndash;29 ml/min/1.73 m<sup>2</sup>).</p><p><strong>Peripheral vascular disease</strong><br />Labetalol should be used with caution in patients with peripheral vascular disease as their symptoms may deteriorate. Caution is advised for patients with peripheral arterial disease (Raynaud syndrome, intermittent claudication), as labetalol may aggravate symptoms. Alpha blockers can counteract the unwanted effect of beta blockers.</p><p><strong>Symptomatic bradycardia</strong><br />The labetalol dose should be decreased if the patient develops symptomatic bradycardia.</p><p><strong>First degree atrioventricular block</strong><br />Due to the negative effect of beta blockers on atrioventricular conduction time, labetalol should be administered with caution to patients with first degree atrioventricular block.</p><p><strong>Diabetes mellitus</strong><br />Caution must be observed in the presence of uncontrolled or difficult-to-control diabetes. As with other beta blockers, labetalol can mask the symptoms of hypoglycaemia (tachycardia and tremor) in diabetic patients. The hypoglycaemic effect of insulin and oral hypoglycaemic agents may be amplified by beta blockers.</p><p><strong>Thyrotoxicosis</strong><br />Beta blockers can mask the symptoms of thyrotoxicosis, however thyroid function is not affected.</p><p><strong>Hypersensitivity to beta blockers</strong><br />Risk of anaphylactic reaction: while taking beta blockers, patients with a history of severe anaphylactic reaction to various allergens may become more reactive to repeated challenges, regardless of whether these are accidental, diagnostic or therapeutic. Such patients might not respond to the usual doses of adrenaline used to treat allergic reactions.</p><p><strong>Adrenaline</strong><br />A reduced adrenaline dose should be used if patients receiving labetalol require treatment with adrenaline, as concurrent administration of labetalol and adrenaline may result in bradycardia and hypertension (see section 4.5 Interaction with other medicinal products and other forms of interaction).</p><p>Labetalol can cause a paradoxical rise in blood pressure if there is a significantly elevated level of adrenaline in the blood, such as in phaeochromocytoma.</p><p><strong>Skin rash and/or dry eyes</strong><br />Skin rash and/or dry eyes have been reported in connection with the use of beta blockers. The reported incidence is small and in most cases the symptoms subsided once the treatment was discontinued. Gradual discontinuation of the medicinal product should be considered if a reaction of this type cannot otherwise be explained.</p><p><strong>Intraoperative Floppy Iris Syndrome</strong><br />The development of intraoperative floppy iris syndrome (IFIS, a type of small pupil syndrome) has been observed in connection with cataract surgery in some patients who were treated with, or previously treated with, tamsulosin. Isolated reports have also been received concerning other alpha-1 blockers; the risk of a drug class effect cannot be excluded. Since IFIS can involve an increase in complications in connection with cataract surgery, the eye surgeon must be informed prior to the procedure of current or previous use of alpha-1 blockers.</p><p><strong>Heart failure or impaired left ventricular function</strong><br />Particular caution must be observed in patients with heart failure or impaired systolic left ventricular function. Labetalol is contraindicated in uncontrolled heart failure, but may be used with caution in symptom-free patients whose condition is well controlled. Heart failure is to be controlled with adequate treatment before using labetalol.</p><p>The use of beta blockers indicates a risk of the development or deterioration of heart failure or obstructive lung disease. In the case of heart failure, the heart muscle&rsquo;s contraction capacity must be maintained, and the failure must be compensated. Patients with reduced contraction capacity, especially the elderly, must be monitored regularly with regard to the development of heart failure.</p><p>It is strongly recommended that Trandate therapy should not be discontinued abruptly, especially in patients with heart failure or angina pectoris (risk of aggravated angina, myocardial infarction and ventricular fibrillation).</p><p><strong>Inhaled anaesthetics</strong><br />Caution should be observed in cases of concurrent treatment with inhaled anaesthetics (see section 4.5 Interaction with other medicinal products and other forms of interaction). It is not necessary to discontinue labetalol therapy prior to anaesthesia however the patient should receive intravenous atropine prior to the administration of the anaesthetic. Labetalol can amplify the hypotensive effects of volatile anaesthetics.</p><p><strong>Metabolic acidosis and pheochromocytoma</strong><br />Caution should be observed in cases of metabolic acidosis and pheochromocytoma. Labetalol should only be administered to patients with pheochromocytoma once adequate alpha blockade has been achieved.</p><p><strong>Calcium antagonists</strong><br />Caution should be observed if labetalol is used concurrently with calcium antagonists, especially calcium channel antagonists, which negatively affect contraction capacity and AV conduction.</p><p>Caution should be observed in cases of concurrent administration of adrenaline, verapamil or class I antiarrhythmics (see section 4.5 Interaction with other medicinal products and other forms of interaction).</p><p>Beta blockers have a negative inotropic effect but do not affect the positive inotropic effect of digitalis.</p><p><strong>Sudden haemorrhage</strong><br />During general anaesthesia, labetalol may mask the compensatory physiological responses to sudden haemorrhage (tachycardia and vasoconstriction). Blood loss and the blood volume maintained must therefore be monitored closely.</p><p><strong>Administration</strong><br />Monitoring of the blood pressure and heart rate after injection and during infusion is recommended. In most patients there is a small decrease in the heart rate. Severe bradycardia is unusual but may be controlled by injecting atropine 1&ndash;2 mg intravenously.</p><p>Respiratory function should be monitored, particularly in patients with any known impairment.</p><p>Once the blood pressure has been reduced to an adequate level by a bolus injection or infusion, treatment should be switched to maintenance therapy with labetalol tablets, with a start dose of 100 mg twice daily.</p><p>Labetalol for injection has been administered to patients with uncontrolled hypertension already receiving other hypotensive agents, including beta blockers, without adverse effects.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>4.5 Interaction with other medicinal products and other forms of interaction</strong></p><p>Concomitant use not recommended:</p><ul><li>Calcium antagonists such as verapamil and to a lesser extent diltiazem have a negative influence on contractility and atrio-ventricular conduction.</li><li>&nbsp;Digitalis glycosides used in association with beta-blockers may increase atrio-ventricular conduction time.</li><li>&nbsp;Clonidine: Beta-blockers increase the risk of rebound hypertension. When clonidine is used in conjunction with non-selective beta-blockers, such as propranolol, treatment with clonidine should be continued for some time after treatment with the beta-blocker has been discontinued.</li><li>&nbsp;Monoamineoxidase inhibitors (except MOA-B inhibitors).</li></ul><p>Use with caution:</p><ul><li>&nbsp;Class I antiarrhythmic agents (e.g. disopyramide, quinidine) and amiodarone (Class II antiarrhythmics) may have potentiating effects on atrial conduction time and induce negative inotropic effect.</li><li>&nbsp;Insulin and oral antidiabetic drugs may intensify the blood sugar lowering effect, especially of non-selective beta-blockers. Beta- blockade may prevent the appearance of signs of hypoglycaemia (tachycardia).</li><li>Anaesthetic drugs may cause attenuation of reflex tachycardia and increase the risk of hypotension. Continuation of beta-blockade reduces the risk of arrhythmia during induction and intubation. The anaesthesiologist should be informed when the patient is receiving a beta- blocking agent. Anaesthetic agents causing myocardial depression, such as cyclopropane and trichlorethylene, are best avoided.</li><li>&nbsp;Cimetidine, hydralazine and alcohol may increase the bioavailability of labetalol.</li><li>Several different drugs or drug classes may enhance the hypotensive effects of labetalol: ACE inhibitors; angiotensin-II antagonists; aldesleukin, alprostadil; anxiolytics; hypnotics; moxisylyte; diuretics; alpha-blockers.</li><li>&nbsp;Several different drugs or drug classes may antagonise the hypotensive effects of labetalol: NSAIDs, corticosteroids; oestrogens; progesterones.</li></ul><p>Take into account:</p><ul><li>&nbsp;Calcium antagonists: dihydropyridine derivates such as nifedipine. The risk of hypotension may be increased. In patients with latent cardiac insufficiency, treatment with beta-blockers may lead to cardiac failure.</li><li>&nbsp;Prostaglandin synthetase inhibiting drugs may decrease the hypotensive effect of beta- blockers.</li><li>Sympathicomimetic agents may counteract the effect of beta-adrenergic blocking agents.</li><li>Concomitant use of tricyclic antidepressants (imipramine), barbiturates, phenothiazines or other antihypertensive agents may increase the blood pressure lowering effect of labetalol. Concomitant use of tricyclic antidepressants may increase the incidence of tremor.</li><li>&nbsp;Labetalol has been shown to reduce the uptake of radioisotopes of metaiodobenzylguanidine (MIBG), and may increase the likelihood of a false negative study. Care should therefore be taken in interpreting results from MIBG scintigraphy. Consideration should be given to withdrawing labetalol for several days at least before MIBG scintigraphy, and substituting other beta or alpha-blocking drugs.</li><li>&nbsp;Antimalarials such as mefloquine or quinine may increase the risk of bradycardia.</li><li>&nbsp;Ergot derivatives may increase the risk of peripheral vasoconstriction.</li><li>Tropisetron may increase the risk of ventricular arrhythmia.</li><li>&nbsp;Labetalol interferes with laboratory tests for catecholamines. Labetalol fluoresces in alkaline solutions with an excitation wavelength of 334 nm and a fluorescence wavelength of 412 nm, and can therefore interact with the analysis of certain fluorescent substances including catecholamines.</li><li>The presence of labetalol metabolites in the urine may indicate falsely elevated levels of urinary catecholamines, metadrenaline, normetadrenaline and vanillylmandelic acid (VMA) when measured by fluorimetric or photometric methods. When patients with suspected pheochromocytoma who are treated with labetalol hydrochloride are screened, a specific method such as high-performance liquid chromatography with solid phase extraction should be used to determine catecholamine levels.</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Fertility</u><br />There is no information on the effect of labetalol on fertility.</p><p><u>Pregnancy</u><br />Based on experience of pregnancy in humans, labetalol is not expected to increase the risk of birth defects. Animal studies do not indicate teratogenicity. However, toxic effects on foetal development have been noted (see section 5.3). Depending on the pharmacological mechanism of action of alpha and beta-adrenoceptor blockade, and when these are used in late pregnancy, undesirable effects to the foetus and the neonate should be taken into consideration (bradycardia, hypotension, respiratory depression, hypoglycaemia), as labetalol crosses the placenta. Beta blockers can reduce the blood flow in the uterus.<br />Labetalol should be only used during pregnancy when the benefits to the mother outweigh the risks for the foetus.</p><p><u>Breastfeeding</u></p><p>Labetalol is excreted in breast milk. Breast feeding is therefore not recommended.</p><ul><li>Nipple pain and Raynaud&#39;s phenomenon of the nipple have been reported (see section 4.8).</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not relevant.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Summary of the safety profile</strong><br />The most common adverse reactions observed with labetalol for injection and gathered from post-marketing reports include: heart failure, postural hypotension, hypersensitivity, drug fever, elevated liver function tests, nasal congestion and erectile dysfunction.</p><p><strong>Tabulated list of adverse reactions</strong></p><p>The following convention has been used to classify the frequency:&nbsp;<br />Very common &ge;1/10<br />Common &ge;1/100 to &lt;1/10&nbsp;<br />Uncommon &ge;1/1,000 to &lt;1/100&nbsp;<br />Rare &ge;1/10,000 to &lt;1/1,000<br />Very rare &lt;1/10,000</p><p>The adverse reactions marked with # are usually transient and occur during the first few weeks of treatment.</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td colspan="2" style="vertical-align:top"><p>Organ system</p></td><td style="vertical-align:top"><p>Adverse reactions</p></td></tr><tr><td style="vertical-align:top"><p>Immune system disorders</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Hypersensitivity, drug fever</p></td></tr><tr><td rowspan="3" style="vertical-align:top"><p>Cardiac disorders</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Heart failure</p></td></tr><tr><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Bradycardia</p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Heart block</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Vascular disorders</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>#Postural hypotension</p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Aggravated symptoms of Raynaud syndrome</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Respiratory, thoracic and mediastinal disorders</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>#Nasal congestion</p></td></tr><tr><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Bronchospasm</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Hepatobiliary disorders</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Elevated liver function tests</p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Hepatitis, hepatocellular jaundice, cholestatic jaundice, hepatic necrosis</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Reproductive system and breast disorders</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Erectile dysfunction</p></td></tr><tr><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Nipple pain, Raynaud&#39;s phenomenon of the nipple</p></td></tr></tbody></table><p><strong>Description of selected adverse reactions:</strong></p><p><strong>Immune system disorders</strong><br />Hypersensitivity reactions including rash, pruritus, dyspnoea and, very rarely, drug fever and angioedema have been reported.</p><p><strong>Vascular disorders</strong><br />Pronounced postural hypotension can occur if patients are permitted to assume an upright position within 3 hours after receiving a labetalol injection.</p><p><strong>Hepatobiliary disorders</strong><br />Signs and symptoms of hepatic and biliary passage disturbances are usually reversible on discontinuation of the medicinal product.</p><p><u>To reports any side effect(s):</u></p><ul><li><strong>Saudi Arabia:</strong></li></ul><table border="1" cellspacing="0" cellpadding="0" style="width:650px"><tbody><tr><td style="vertical-align:top; width:647px"><ul><li>The National Pharmacovigilance Centre (NPC):</li></ul><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SFDA Call Center: 19999</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: https://ade.sfda.gov.sa/</p></td></tr></tbody></table><p><strong>-&nbsp;&nbsp;&nbsp;&nbsp;Other GCC States:</strong></p><table border="1" cellspacing="1" cellpadding="1" style="width:653px"><tbody><tr><td style="width:650px">-&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Please contact the relevant competent authority.</td></tr></tbody></table><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Symptoms and signs:</u><br />Significant cardiovascular effects can be expected, e.g. excessive postural hypotension and occasional bradycardia. Renal failure with oliguria has been reported following massive overdose of oral labetalol. In one case, the use of dopamine to increase blood pressure may have aggravated the renal failure.</p><p><u>Treatment:</u><br />The patient should be recumbent, with the legs in an elevated position.<br />Parenteral adrenergic/anticholinergic treatment should be administered as required, to improve circulation.<br />Haemodialysis removes less than 1 % of labetalol hydrochloride from the blood circulation. Continued management is to proceed according to the clinical indications or as recommended by the Poisons Information Centre, if available.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Alpha and beta blocking agents, ATC code: C07AG01</p><p><strong>Mechanism of action</strong><br />Labetalol lowers the blood pressure by blocking alpha adrenoceptors on peripheral arterioles, thus reducing the peripheral resistance; the concurrent beta blockade protects the heart from the reflex sympathetic drive that would otherwise occur.</p><p><strong>Pharmacodynamic effects</strong><br />Cardiac output is not significantly reduced at rest or after moderate exertion. The increase in systolic blood pressure during exertion is reduced, but the corresponding changes in the diastolic pressure are essentially normal. All these effects would be expected to benefit hypertensive patients.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u><strong>Pharmacokinetics</strong></u><br />Chemically, labetalol consists of four stereoisomers with different pharmacodynamic effects.</p><p><strong>Distribution</strong><br />Labetalol is around 50 % protein bound in the blood. In animal studies, only negligible amounts of labetalol have passed the blood-brain barrier. Labetalol passes the placental barrier and is excreted in human milk.</p><p><strong>Biotransformation</strong><br />Labetalol is metabolised primarily through conjugation to inactive glucuronide metabolites.</p><p><strong>Elimination</strong><br />The glucuronide metabolites are excreted both in urine and via the bile into the faeces. Less than 5 % of the labetalol dose is excreted unmodified in the urine and bile. The half life of labetalol in plasma is approximately 4 hours.</p><p><u><strong>Specific patient populations</strong></u></p><ul><li><strong>Hepatic failure</strong></li></ul><p>Labetalol undergoes significant but varying first pass metabolism when administered orally. In a study of 10 patients with histologically confirmed cirrhosis, the exposure for oral labetalol increased approximately threefold compared with the healthy control group.</p><p>Individual variations in both patients and the control group were large (approximately 2.5 times). Patients with hepatic failure may require lower oral doses of labetalol (see section 4.2 Posology and method of administration and section 4.4 Special warnings and precautions for use).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <ul><li><u>&nbsp;Carcinogenic, mutagenic and teratogenic effects</u></li></ul><p>No signs of mutagenic potential were seen in in vitro and in vivo examinations.</p><p>Labetalol showed no signs of carcinogenicity in long-term studies of mice and rats.</p><p>No teratogenicity was observed in rats and rabbits at oral doses of 6 and 4 times the maximum recommended human dose. Increased foetal resorptions were seen in both species at doses approaching the maximum recommended human dose. A teratology study performed with labetalol in rabbits with intravenous doses up to 1.7 times the maximum recommended human dose gave no evidence of drug-related foetal injury.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Dilute Hydrochloric acid or sodium hydroxide for adjustment to pH 4.</p><p>Water for injections.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Labetalol must not be mixed with sodium bicarbonate solution for injection.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years.

The prepared solution for infusion has a shelf life of 24 hours.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 25 C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pack of 5x20 ml (glass ampoule).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Aspen Pharma Trading Limited 
3016 Lake Drive
Citywest Business Campus 
Dublin 24, Ireland
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                February 2022
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>